Article Versions Notes

Abdelgawad MA, El-Adl K, El-Hddad SSA, Elhady MM, Saleh NM, Khalifa MM, Khedr F, Alswah M, Nayl AA, Ghoneim MM, et al. Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists. Pharmaceuticals. 2022; 15(2):226. https://doi.org/10.3390/ph15020226

Abdelgawad, Mohamed A., Khaled El-Adl, Sanadelaslam S. A. El-Hddad, Mostafa M. Elhady, Nashwa M. Saleh, Mohamed M. Khalifa, Fathalla Khedr, Mohamed Alswah, AbdElAziz A. Nayl, Mohammed M. Ghoneim, and et al. 2022. "Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists" Pharmaceuticals 15, no. 2: 226. https://doi.org/10.3390/ph15020226

Abdelgawad, M. A., El-Adl, K., El-Hddad, S. S. A., Elhady, M. M., Saleh, N. M., Khalifa, M. M., Khedr, F., Alswah, M., Nayl, A. A., Ghoneim, M. M., & Abd El-Sattar, N. E. A. (2022). Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists. Pharmaceuticals, 15(2), 226. https://doi.org/10.3390/ph15020226